Communiqués Laboratorios Farmaceuticos Rovi, S.A.

Actions

ROVI

ES0157261019

Marché Fermé - BME Autres places de cotation 17:35:28 11/06/2024			Varia. 5j.	Varia. 1 janv.
87,8 ^EUR	-1,51 %		-1,07 %	+45,85 %

08/05	Laboratorios Farmaceuticos Rovi, S.A. publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
29/04	AVIS D'ANALYSTES DU JOUR : Hermès, Orange, Renault, TotalEnergies, Rémy Cointreau, Amundi, UBS...

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Laboratorios Farmaceuticos Rovi S A : First three months 2024 results press release	08/05	PU
Laboratorios Farmaceuticos Rovi S A : ROVI announces agreement to manufacture pre-filled syringes	25/04	PU
Laboratorios Farmaceuticos Rovi S A : ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies	12/03	PU
Laboratorios Farmaceuticos Rovi S A : First nine months 2023 results press release	10/11	PU
Laboratorios Farmaceuticos Rovi S A : ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®	28/07/23	PU
Laboratorios Farmaceuticos Rovi S A : First half 2023 results press release	26/07/23	PU
Laboratorios Farmaceuticos Rovi S A : First quarter 2023 results press release	10/05/23	PU
Laboratorios Farmaceuticos Rovi S A : ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)	25/04/23	PU
Laboratorios Farmaceuticos Rovi S A : ROVI plants a forest with 2,000 trees in the Madrid Sierra	27/03/23	PU
Laboratorios Farmaceuticos Rovi S A : BioSim strengthens its national representation with the incorporation of ROVI Pharmaceutical Laboratories	21/03/23	PU
Laboratorios Farmaceuticos Rovi S A : Full Year 2022 Results Press Release	21/02/23	PU
Laboratorios Farmaceuticos Rovi S A : ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®	16/02/23	PU
Laboratorios Farmaceuticos Rovi S A : ROVI launches an initiative to develop solutions that improve sustained-release injectable drug delivery technologies	24/11/22	PU
Laboratorios Farmaceuticos Rovi S A : First nine months 2022 results press release	04/11/22	PU
Laboratorios Farmaceuticos Rovi S A : The President of the Andalusian Government, Juan Manel Moreno, visits the new Rovi plant in Escúzar (Granada)	24/10/22	PU
Laboratorios Farmaceuticos Rovi S A : ROVI tops the Sustainalytics sustainability ranking for the pharmaceutical subindustry worldwide	01/08/22	PU
Laboratorios Farmaceuticos Rovi S A : First half 2022 results press release	27/07/22	PU
Laboratorios Farmaceuticos Rovi S A : ROVI receives the positive opinion of the CHMP on Okedi® as a treatment for schizophrenia	17/12/21	PU
First nine months 2021 results press release	03/11/21	PU
ROVI Share Buyback Program	03/11/21	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Focus : Rovi, le laboratoire pharmaceutique qui venait du sud

Le 20 septembre 2022 à 10:45